## ACT: Enact Holdings, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 0.3% below STRENGTH zone (4.0-10.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($37.23)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Enact Holdings (ACT): Assessing Valuation After Recent Share Price Momentum**
- Source: Yahoo Finance | 20251202T161300 | Somewhat-Bullish | Relevance: 100%
- Enact Holdings (ACT) shares have seen recent momentum, gaining nearly 9% in a month and 20% year-to-date, with a 79% total return over three years. Despite this, the company is considered to be undervalued, trading slightly below analysts' fair value estimates, driven by strong homebuyer demand and home price appreciation. However, persistently high mortgage rates could negatively impact its outlook.

**2. JPMorgan Retains Neutral Stance on Enact (ACT) Despite Minor Target Trim**
- Source: Insider Monkey | 20251201T194900 | Neutral | Relevance: 100%
- JPMorgan's Richard Shane has reaffirmed a Neutral rating for Enact Holdings, Inc. (NASDAQ:ACT) while slightly lowering the price target from $40 to $39. This decision follows the company's third-quarter update, where it reported $311.4 million in total revenue and $14 billion in new insurance written, an increase from the previous quarter and year. Enact Holdings continues to focus on shareholder returns, distributing $31 million in dividends during the period.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-07 | JP Morgan | $39 | $40 | -2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-07 | JP Morgan | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 15 ($0.00M) |
| Sells | 5 ($102.59M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 13.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Blackrock Inc.: 3.2% (+1.0%)
- Vanguard Group Inc: 2.2% (-2.0%)
- Dimensional Fund Adv: 1.9% (+7.1%)
- First Trust Advisors: 1.0% (+87.9%)
- Qube Research & Tech: 1.0% (+289.4%)

### Key Risks

1. Heavy insider selling: $103M sold (5 transactions in 90 days).
2. High short interest (15.7%, 12.3 days to cover): squeeze risk or crowded bearish bet.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

Forward P/E 8.3x stretched relative to 4% growth. Quality metrics strong (margin 54%). Balance sheet: strong liquidity (6612078000.0x), low leverage (D/E 0.29). Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($102.6M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.9B |
| Beta | 0.52 |
| 52W Range | $30.79 - $40.88 |
| Short Interest | 15.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | N/A |
| Forward P/E | 8.3 |
| Current P/E | 8.6 |
| YoY Growth | 3.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.0% to 0.3% (-3.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.6pp (needs >4.0% for momentum thesis). MRS_5 (-1.0%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -MUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.35% (CS: 54) | Neutral |
| RSI_14 | 60.1 | Neutral |
| MACD Histogram | 0.09 | Bullish |
| vs SMA20 | 1.019x | Above |
| vs SMA50 | 1.043x | Above |
| vs SMA200 | 1.070x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $38.61
- **Stop Loss:** $37.23 (3.6% risk)
- **Target:** $39.99 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 688
- **Position Value:** $26,563.68
- **Portfolio %:** 26.56%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-04 (Est: $1.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.11 | $1.12 | +0.9% |
| 2025Q2 | $1.11 | $1.15 | +3.9% |
| 2025Q1 | $1.09 | $1.10 | +0.9% |
| 2024Q4 | $1.08 | $1.09 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*